Delivery Order SPE2DB24D2212-SPE2DB25FHPWC

Award Date 5/22/25
Potential Completion Date 6/13/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm-fixed-price contract is for the supply of the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of February 3, 2025. The award is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.23 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a medication, with a ceiling value of $13,846.97. The contract is a firm fixed-price delivery order with a period of performance through May 21, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the drug VYNDAQEL 20 MG CAPSULE UD 120S, with a completion date of July 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a completion date of May 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $56,354.01, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. The contract was not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,846.97, is for the supply of the prescription drug VYNDAQEL 20 MG CAPSULE UD 120S. It is a firm fixed-price contract with a period of performance through May 20, 2025. The contract is not designated as a set-aside and was openly competed. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $18,157.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a completion date of November 18, 2024 and was awarded on October 25, 2024. The award is not designated as a set-aside contract. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,784.67, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S. The contract is a firm fixed-price delivery order with a completion date of February 21, 2025. The award is not associated with a set-aside program and was competitively awarded. Amerisourcebergen Drug Corp is a for-profit organization that specializes in distributing...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPWC
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $13,846.97 firm fixed-price contract is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a medication. The award is not set aside and has an ultimate completion date of June 13, 2025.

AmerisourceBergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely part of the company's broader efforts to fulfill varied federal medical supply requirements through this larger IDC contract vehicle.

Generated 8/21/25, 9:59 AM